Premium
Vitamin B3 levels in women who experience first‐trimester miscarriage
Author(s) -
Yakob Nurul A.,
Peek Michael J.,
Quinlivan Julie A.
Publication year - 2021
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/ajo.13341
Subject(s) - miscarriage , niacin , medicine , pregnancy , obstetrics , first trimester , prospective cohort study , gynecology , gestation , endocrinology , biology , genetics
Miscarriage is the most common complication in early pregnancy. It was recently reported in mice that miscarriage can be prevented through the administration of niacin. We conducted a prospective, exploratory pilot study involving 24 women who were less than 14 weeks pregnant. Neither niacin intake ( P = 0.24) nor urinary vitamin B3 measured as the 1‐methyl‐5‐carboxylamide‐2‐pyridone/ N ‐1‐methylnicotinamide (2‐pyr/MNA) ratio ( P = 1.00) predicted miscarriage. However, the difference in mean 2‐pyr/MNA ratios between women who miscarried and controls suggests there may be a threshold niacin level protective in miscarriage prevention warranting further investigation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom